t
10 February 2026
INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Restatement of Net Asset Value(s)
The Board of International Biotechnology Trust plc (the "Company") announces that, due to an administrative error relating to the non-accrual of the Company's most recent interim dividend, the Company's unaudited cum income net asset value ("NAV") per share has been restated for the following dates, as follows:
|
Date |
Published Cum Income NAV per Share |
Revised Cum Income NAV per Share |
|
29/12/2025 |
1021.50 |
1005.87 |
|
30/12/2025 |
1016.30 |
1000.69 |
|
31/12/2025 |
1024.00 |
1008.35 |
|
02/01/2026 |
1013.20 |
997.59 |
|
05/01/2026 |
998.07 |
982.44 |
|
06/01/2026 |
1004.10 |
988.51 |
|
07/01/2026 |
1035.70 |
1020.10 |
|
08/01/2026 |
1025.30 |
1009.67 |
|
09/01/2026 |
1032.20 |
1016.53 |
|
12/01/2026 |
1010.90 |
995.29 |
|
13/01/2026 |
1007.40 |
991.72 |
|
14/01/2026 |
1031.00 |
1015.36 |
|
15/01/2026 |
1021.10 |
1005.51 |
|
16/01/2026 |
1013.60 |
997.96 |
|
19/01/2026 |
1009.70 |
994.04 |
As a result, the Company's service providers have implemented corrective measures and enhanced their procedures.
Enquiries:
Natalia de Sousa
Schroder Investment Management Limited
Tel: 020 7658 6000
| TIDM | IBT |
| Share Price | 1,123.99p-0.89% |
| Market Cap | £465.15m |
On 10 February 2026, the Board of International Biotechnology Trust PLC announced a restatement of its unaudited cum income net asset value (NAV) per share. This restatement, attributed to an administrative error concerning the non-accrual of the Company's most recent interim dividend, affects NAVs for dates ranging from 29 December 2025 to 19 January 2026, with specific revised figures provided for each date.
| Date | 10 Feb 2026 |
| Time | 12:02:43 |
| Category | Miscellaneous |
| ID | 4572S |